{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:42Z","timestamp":1790776842753,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,19]],"date-time":"2027-08-19T00:00:00Z","timestamp":1818633600000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gassur.2026.102541","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:04:21Z","timestamp":1785996261000},"page":"102541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in the management of colorectal liver metastases: 2026 Society for Surgery of the Alimentary Tract\u2013Society of Surgical Oncology Joint Expert Symposium at Digestive Disease Week"],"prefix":"10.1016","volume":"30","author":[{"given":"Ajay V.","family":"Maker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Newhook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender","family":"Dulundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1245\/s10434-016-5506-7","article-title":"Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database","volume":"23","author":"Hallet","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2026.102541_bib2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/bjs.10191","article-title":"Factors influencing recurrence following initial hepatectomy for colorectal liver metastases","volume":"103","author":"Hallet","year":"2016","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.gassur.2026.102541_bib3","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1245\/s10434-023-14806-4","article-title":"Local therapy improves survival for early recurrence after resection of colorectal liver metastases","volume":"31","author":"Boyev","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s40425-019-0769-8","article-title":"Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment","volume":"7","author":"Newey","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"25","key":"10.1016\/j.gassur.2026.102541_bib6","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib8","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41591-024-03083-7","article-title":"Botensilimab plus balstilimab in relapsed\/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial","volume":"30","author":"Bullock","year":"2024","journal-title":"Nat Med"},{"issue":"41","key":"10.1016\/j.gassur.2026.102541_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv9161","article-title":"Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases","volume":"11","author":"Keenan","year":"2025","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.gassur.2026.102541_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.gassur.2023.12.026","article-title":"Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases","volume":"28","author":"Pollini","year":"2024","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.gassur.2026.102541_bib11","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1158\/0008-5472.CAN-16-1655","article-title":"LIGHT elevation enhances immune eradication of colon cancer metastases","volume":"77","author":"Qiao","year":"2017","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.gassur.2026.102541_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1158\/2326-6066.CIR-14-0212","article-title":"Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases","volume":"3","author":"Maker","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib13","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1245\/s10434-025-17599-w","article-title":"Novel computational analysis identifies cytotoxic lymphocyte-to-monocyte balance in tumors as a predictor of recurrence-free survival in colorectal carcinoma","volume":"32","author":"Fernandez","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib14","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1245\/s10434-025-17728-5","article-title":"ASO author reflections: precision immunoprofiling of the tumor microenvironment predicts recurrence in advanced colorectal cancer","volume":"32","author":"Todeschini","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gassur.2026.102541_bib15","series-title":"Hepatic arterial infusion for malignancy","first-page":"311","article-title":"Novel agents and drug development","author":"Schwantes","year":"2025"},{"issue":"17","key":"10.1016\/j.gassur.2026.102541_bib16","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.2016.71.8346","article-title":"Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: a propensity score analysis","volume":"35","author":"Groot Koerkamp","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9617","key":"10.1016\/j.gassur.2026.102541_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gassur.2026.102541_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SLA.0000000000001194","article-title":"Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival","volume":"263","author":"Mise","year":"2016","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.gassur.2026.102541_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"issue":"33","key":"10.1016\/j.gassur.2026.102541_bib21","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.gassur.2026.102541_bib22","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","article-title":"Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases","volume":"302","author":"Chun","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162400","article-title":"Adjuvant oral uracil-tegafur with leucovorin for colorectal cancer liver metastases: a randomized controlled trial","volume":"11","author":"Hasegawa","year":"2016","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.gassur.2026.102541_bib24","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","article-title":"Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial","volume":"24","author":"Portier","year":"2006","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.gassur.2026.102541_bib25","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO-25-01231","article-title":"Randomized phase II\/III trial comparing hepatectomy, followed by mFOLFOX6 with hepatectomy alone for liver metastasis from colorectal cancer: long-term results of JCOG0603","volume":"44","author":"Kanemitsu","year":"2026","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102541_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.annonc.2024.08.2240","article-title":"Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan Galaxy","volume":"35","author":"Kataoka","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gassur.2026.102541_bib27","first-page":"1","article-title":"Circulating tumor DNA status and adjuvant chemotherapy in resected colorectal liver metastases","author":"Kataoka","year":"2026","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102541_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial","volume":"15","author":"Primrose","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2026.102541_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1470-2045(19)30798-3","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial","volume":"21","author":"Bridgewater","year":"2020","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.gassur.2026.102541_bib30","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.gassur.2026.102541_bib31","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1200\/JCO.2012.45.2854","article-title":"Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases","volume":"30","author":"Shindoh","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2026.102541_bib32","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/annonc\/mdy140","article-title":"Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO","volume":"29","author":"Cremolini","year":"2018","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2026.102541_bib33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/sj.bjc.6605940","article-title":"Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial","volume":"103","author":"Garufi","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gassur.2026.102541_bib34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/annonc\/mdu580","article-title":"Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial","volume":"26","author":"Gruenberger","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2026.102541_bib35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(23)00219-X","article-title":"First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group","volume":"24","author":"Bond","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoncol.2024.5174","article-title":"First-line systemic treatment for initially unresectable colorectal liver metastases: post hoc analysis of the CAIRO5 randomized clinical trial","volume":"11","author":"Bond","year":"2025","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102541_bib37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.gassur.2026.102541_bib38","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2024.02.006","article-title":"Outcomes of high-grade immune checkpoint inhibitor hepatitis in hospitalized and nonhospitalized patients","volume":"22","author":"Li","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.gassur.2026.102541_bib39","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2026.102541_bib40","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/bjs.10572","article-title":"Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases","volume":"104","author":"Zhao","year":"2017","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2017.02.031","article-title":"Reversibility of chemotherapy-related liver injury","volume":"67","author":"Vigano","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.gassur.2026.102541_bib42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"issue":"31","key":"10.1016\/j.gassur.2026.102541_bib43","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.gassur.2026.102541_bib45","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1245\/s10434-015-4533-0","article-title":"Nodular regenerative hyperplasia in patients undergoing liver resection for colorectal metastases after chemotherapy: risk factors, preoperative assessment and clinical impact","volume":"22","author":"Vigan\u00f2","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102541_bib46","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","article-title":"Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases","volume":"17","author":"Kishi","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2017.01.031","article-title":"Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases","volume":"67","author":"Yamashita","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1245\/s10434-025-18413-3","article-title":"Short- and long-term outcomes after hepatectomy in patients receiving triplet versus doublet preoperative chemotherapy for colorectal liver metastases","volume":"33","author":"De Rose","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2026.102541_bib49","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/sj.bjc.6603670","article-title":"Safe liver resection following chemotherapy for colorectal metastases is a matter of timing","volume":"96","author":"Welsh","year":"2007","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.gassur.2026.102541_bib50","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/jso.26832","article-title":"Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases","volume":"125","author":"Sutton","year":"2022","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12957-023-03127-1","article-title":"Clinical outcomes of parenchymal-sparing versus anatomic resection for colorectal liver metastases: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2026.102541_bib52","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1245\/s10434-015-5009-y","article-title":"Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort","volume":"23","author":"Vigan\u00f2","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib53","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1245\/s10434-025-18922-1","article-title":"Oncological adequacy of R1 vascular margin in minimally invasive liver surgery for hepatocellular carcinoma and colorectal liver metastases: a meta-analysis","volume":"33","author":"Procopio","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/SLA.0000000000006891","article-title":"From cherry picking to R1vasc, clusters, and compass points: evolution, technique, and results of parenchymal-sparing One Stage Hepatectomy for multiple colorectal liver metastases","volume":"282","author":"Torzilli","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2026.102541_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2023.03.038","article-title":"A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC)","volume":"187","author":"Tinguely","year":"2023","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.gassur.2026.102541_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","article-title":"Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial","volume":"26","author":"van der Lei","year":"2025","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib57","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1245\/s10434-026-19621-1","article-title":"Long-term oncological outcomes after laparoscopic resection and thermal ablation of colorectal liver metastases within a parenchyma-sparing strategy","volume":"33","author":"Hansen","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2468-1253(25)00024-X","article-title":"Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial","volume":"10","author":"Odisio","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jso.25430","article-title":"Dealing with an insufficient future liver remnant: portal vein embolization and two-stage hepatectomy","volume":"119","author":"Kawaguchi","year":"2019","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib60","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jso.25435","article-title":"Dealing with insufficient liver remnant: associating liver partition and portal vein ligation for staged hepatectomy","volume":"119","author":"Linecker","year":"2019","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102541_bib61","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/SLA.0000000000005640","article-title":"Ex vivo liver resection and autotransplantation: should it be used more frequently?","volume":"276","author":"Weiner","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.gassur.2026.102541_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1088\/0031-9155\/59\/2\/253","article-title":"Effects of tissue mechanical properties on susceptibility to histotripsy-induced tissue damage","volume":"59","author":"Vlaisavljevich","year":"2014","journal-title":"Phys Med Biol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib63","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2026.102541_bib64","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamasurg.2019.1694","article-title":"Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review","volume":"154","author":"Datta","year":"2019","journal-title":"JAMA Surg"},{"issue":"10458","key":"10.1016\/j.gassur.2026.102541_bib65","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","article-title":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","volume":"404","author":"Adam","year":"2024","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.gassur.2026.102541_bib66","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1200\/JCO.18.01798","article-title":"Mutational analysis of patients with colorectal cancer in CALGB\/SWOG 80405 identifies new roles of microsatellite instability and tumor mutational burden for patient outcome","volume":"37","author":"Innocenti","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102541_bib67","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group","volume":"27","author":"Modest","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102541_bib68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12876-021-01864-9","article-title":"Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis","volume":"21","author":"Fang","year":"2021","journal-title":"BMC Gastroenterol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X26002222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X26002222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:31:31Z","timestamp":1790775091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X26002222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1091255X26002222"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102541","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the management of colorectal liver metastases: 2026 Society for Surgery of the Alimentary Tract\u2013Society of Surgical Oncology Joint Expert Symposium at Digestive Disease Week","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102541"}}